Segall Bryant & Hamill, LLC Meridian Bioscience Inc Transaction History

Segall Bryant & Hamill, LLC

  • $7.16 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$15.51 - $17.61 $1.32 Million - $1.5 Million
-84,905 Reduced 34.02%
164,672 $0
Q4 2018

Feb 15, 2019
SELL
$14.52 - $19.72 $404,672 - $549,596
-27,870 Reduced 10.05%
249,577 $4.33 Million
Q3 2018

Nov 14, 2018
BUY
$14.85 - $16.35 $973,580 - $1.07 Million
65,561 Added 30.94%
277,447 $0
Q2 2018

Aug 08, 2018
BUY
$13.8 - $16.8 $2.92 Million - $3.56 Million
211,886 New
211,886 $0

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email